These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 27163502

  • 41. An open label, active controlled, multicentric clinical trial to assess the efficacy and safety of fluticasone furoate nasal spray in adult Indian patients suffering from allergic rhinitis.
    Kubavat AH, Pawar P, Mittal R, Sinha V, Shah UB, Ojha T, Khippal N, Patel T.
    J Assoc Physicians India; 2011 Jul; 59():424-8. PubMed ID: 22315746
    [Abstract] [Full Text] [Related]

  • 42. A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD.
    Agustí A, de Teresa L, De Backer W, Zvarich MT, Locantore N, Barnes N, Bourbeau J, Crim C.
    Eur Respir J; 2014 Mar; 43(3):763-72. PubMed ID: 24114969
    [Abstract] [Full Text] [Related]

  • 43. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis.
    Kaiser HB, Naclerio RM, Given J, Toler TN, Ellsworth A, Philpot EE.
    J Allergy Clin Immunol; 2007 Jun; 119(6):1430-7. PubMed ID: 17418384
    [Abstract] [Full Text] [Related]

  • 44. A role for the intranasal formulation of azelastine hydrochloride/fluticasone propionate in the treatment of allergic rhinitis.
    Ridolo E, Montagni M, Melli V, Bonzano L, Incorvaia C, Canonica GW.
    Ther Deliv; 2015 Jun; 6(6):653-9. PubMed ID: 25913181
    [Abstract] [Full Text] [Related]

  • 45. Safety, tolerability, pharmacokinetics, and pharmacodynamics of fluticasone furoate, a novel inhaled corticosteroid, in children aged 5-11 years with persistent asthma: A randomized trial.
    Oliver A, Allen A, VanBuren S, Hamilton M, Tombs L, Kempsford R, Qaqundah P.
    Clin Pharmacol Drug Dev; 2014 Mar; 3(2):144-50. PubMed ID: 27128459
    [Abstract] [Full Text] [Related]

  • 46. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen.
    Fokkens WJ, Jogi R, Reinartz S, Sidorenko I, Sitkauskiene B, van Oene C, Faris MA, Ellsworth A, Caldwell MF.
    Allergy; 2007 Sep; 62(9):1078-84. PubMed ID: 17686111
    [Abstract] [Full Text] [Related]

  • 47. Effectiveness of Fluticasone Furoate-Vilanterol for COPD in Clinical Practice.
    Vestbo J, Leather D, Diar Bakerly N, New J, Gibson JM, McCorkindale S, Collier S, Crawford J, Frith L, Harvey C, Svedsater H, Woodcock A, Salford Lung Study Investigators.
    N Engl J Med; 2016 Sep 29; 375(13):1253-60. PubMed ID: 27593504
    [Abstract] [Full Text] [Related]

  • 48. Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis.
    Lange B, Lukat KF, Rettig K, Holtappels G, Bachert C.
    Ann Allergy Asthma Immunol; 2005 Sep 29; 95(3):272-82. PubMed ID: 16200819
    [Abstract] [Full Text] [Related]

  • 49. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
    Kim S, Jang IJ, Shin D, Shin DS, Yoon S, Lim KS, Yu KS, Li J, Zhang H, Liu Y, Brendel E, Blode H, Wang Y.
    J Clin Pharm Ther; 2014 Aug 29; 39(4):424-31. PubMed ID: 24806030
    [Abstract] [Full Text] [Related]

  • 50. Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber.
    Zieglmayer P, Zieglmayer R, Bareille P, Rousell V, Salmon E, Horak F.
    Curr Med Res Opin; 2008 Jun 29; 24(6):1833-40. PubMed ID: 18498678
    [Abstract] [Full Text] [Related]

  • 51. Fluticasone furoate/vilanterol combination for the treatment of COPD and asthma.
    Rogliani P, Matera MG, Cazzola M.
    Drugs Today (Barc); 2015 Aug 29; 51(8):469-78. PubMed ID: 26380385
    [Abstract] [Full Text] [Related]

  • 52. Pharmacokinetics of intranasal mometasone in the fixed-dose combination GSP301 versus two monotherapy intranasal mometasone formulations.
    Patel P, Salapatek AM, Talluri RS, Tantry SK.
    Allergy Asthma Proc; 2018 May 01; 39(3):232-239. PubMed ID: 29669668
    [Abstract] [Full Text] [Related]

  • 53. Deposition of intranasal glucocorticoids--preliminary study.
    Rapiejko P, Sosnowski TR, Sova J, Jurkiewicz D.
    Otolaryngol Pol; 2015 May 01; 69(6):30-8. PubMed ID: 26860605
    [Abstract] [Full Text] [Related]

  • 54. Comparison of fluticasone furoate and fluticasone propionate for the treatment of Japanese cedar pollinosis.
    Okubo K, Nakashima M, Miyake N, Komatsubara M, Okuda M.
    Allergy Asthma Proc; 2009 May 01; 30(1):84-94. PubMed ID: 19061537
    [Abstract] [Full Text] [Related]

  • 55. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate.
    Wardlaw A, Larivee P, Eller J, Cockcroft DW, Ghaly L, Harris AG.
    Ann Allergy Asthma Immunol; 2004 Jul 01; 93(1):49-55. PubMed ID: 15281471
    [Abstract] [Full Text] [Related]

  • 56. The efficacy of once-daily fluticasone furoate/vilanterol in asthma is comparable with morning or evening dosing.
    Kempsford RD, Oliver A, Bal J, Tombs L, Quinn D.
    Respir Med; 2013 Dec 01; 107(12):1873-80. PubMed ID: 24200619
    [Abstract] [Full Text] [Related]

  • 57. A review of the use of fluticasone furoate since its launch.
    Villa E, Magnoni MS, Micheli D, Canonica GW.
    Expert Opin Pharmacother; 2011 Sep 01; 12(13):2107-17. PubMed ID: 21797803
    [Abstract] [Full Text] [Related]

  • 58. Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis.
    Nathan RA, Berger W, Yang W, Cheema A, Silvey M, Wu W, Philpot E.
    Ann Allergy Asthma Immunol; 2008 May 01; 100(5):497-505. PubMed ID: 18517084
    [Abstract] [Full Text] [Related]

  • 59. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.
    Mandl M, Nolop K, Lutsky BN.
    Ann Allergy Asthma Immunol; 1997 Sep 01; 79(3):237-45. PubMed ID: 9305231
    [Abstract] [Full Text] [Related]

  • 60. Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations.
    Daley-Yates PT, Baker RC.
    Br J Clin Pharmacol; 2001 Jan 01; 51(1):103-5. PubMed ID: 11167672
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.